No Data
No Data
BEXCELLENT GP: Annual Report 2024
BExcellent Group Shrinks Loss by 12% in Fiscal Year 2024
Bexcellent gp (01775.HK) annual revenue increased by 19.8% year-on-year to 0.157 billion Hong Kong dollars.
October 30th, Jingyinghui Group (01775.HK) announced that as of the fiscal year ending July 31, 2024, the group's revenue increased by 19.8% year-on-year to 0.157 billion Hong Kong dollars. The total number of students taking courses in private secondary school auxiliary education services decreased by 8.3% from 0.132 million to 0.121 million. The group's loss decreased by 13.5% year-on-year to 23.3 million Hong Kong dollars. The group's adjusted loss decreased by 27.0% year-on-year to 23.2 million Hong Kong dollars. The loss attributable to company owners decreased by 11.6% from 27.8 million Hong Kong dollars to 24.6 million Hong Kong dollars during the reporting period, the group's revenue.
BEXCELLENT GP: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 JULY 2024
Bexcellent gp (01775.HK): Dai Guoliang appointed as an independent non-executive director.
On July 2, Gelonghui reported that Bexcellent gp (01775.HK) announced that Professor Shiquan Wang has resigned as an independent non-executive director and the resignation will take effect from July 1, 2024. Due to Professor Wang's approaching eightieth birthday, he has requested to resign in order to enjoy his retirement. In order to fill the vacancy in the board of directors after Professor Wang's resignation, Mr. Guoliang Dai has been appointed as an independent non-executive director, effective from July 1, 2024.
Bexcellent GP has appointed ShineWing Zhonghua as the new auditor.
Bexcellent gp (01775) has announced that PwC has resigned as the company's auditor effective from June 17, 2024, based on the consensus between the company and PwC. Following the recommendation of the audit committee, the board of directors has appointed Ernst & Young Zhonghua (Hong Kong) as the new auditor to fill the temporary vacancy left by PwC's resignation. The appointment will take effect on June 17, 2024, and will expire until the end of the next shareholder's annual meeting.
No Data
No Data